Cargando…

Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest

The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Ruixue, Vos, Harmjan R, van Es, Robert M, Chen, Jing, Burgering, Boudewijn MT, Westendorp, Bart, de Bruin, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830916/
https://www.ncbi.nlm.nih.gov/pubmed/29363506
http://dx.doi.org/10.15252/embj.201797877
_version_ 1783303088685187072
author Yuan, Ruixue
Vos, Harmjan R
van Es, Robert M
Chen, Jing
Burgering, Boudewijn MT
Westendorp, Bart
de Bruin, Alain
author_facet Yuan, Ruixue
Vos, Harmjan R
van Es, Robert M
Chen, Jing
Burgering, Boudewijn MT
Westendorp, Bart
de Bruin, Alain
author_sort Yuan, Ruixue
collection PubMed
description The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post‐translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14‐3‐3 protein isoforms interact with both E2Fs in a Chk1‐dependent manner. Strikingly, Chk1 phosphorylation and 14‐3‐3‐binding did not relocate or degrade atypical E2Fs, but instead, 14‐3‐3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14‐3‐3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14‐3‐3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA‐damaging therapeutic reagents.
format Online
Article
Text
id pubmed-5830916
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58309162018-03-14 Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest Yuan, Ruixue Vos, Harmjan R van Es, Robert M Chen, Jing Burgering, Boudewijn MT Westendorp, Bart de Bruin, Alain EMBO J Articles The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S‐phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post‐translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14‐3‐3 protein isoforms interact with both E2Fs in a Chk1‐dependent manner. Strikingly, Chk1 phosphorylation and 14‐3‐3‐binding did not relocate or degrade atypical E2Fs, but instead, 14‐3‐3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14‐3‐3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14‐3‐3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA‐damaging therapeutic reagents. John Wiley and Sons Inc. 2018-01-23 2018-03-01 /pmc/articles/PMC5830916/ /pubmed/29363506 http://dx.doi.org/10.15252/embj.201797877 Text en © 2018 The Authors. Published under the terms of the CC BY NC ND 4.0 license This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Yuan, Ruixue
Vos, Harmjan R
van Es, Robert M
Chen, Jing
Burgering, Boudewijn MT
Westendorp, Bart
de Bruin, Alain
Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title_full Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title_fullStr Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title_full_unstemmed Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title_short Chk1 and 14‐3‐3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
title_sort chk1 and 14‐3‐3 proteins inhibit atypical e2fs to prevent a permanent cell cycle arrest
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830916/
https://www.ncbi.nlm.nih.gov/pubmed/29363506
http://dx.doi.org/10.15252/embj.201797877
work_keys_str_mv AT yuanruixue chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT vosharmjanr chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT vanesrobertm chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT chenjing chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT burgeringboudewijnmt chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT westendorpbart chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest
AT debruinalain chk1and1433proteinsinhibitatypicale2fstopreventapermanentcellcyclearrest